ro com glp 1 Launches Weight Loss Program With GLP-1 Medications, Lab Testing, 1:1 Coaching, and Personalized Provider Care Ro Launches GLP-1 Insurance Coverage

Many of the subcutaneous products are administered once weekly, which contributes to medication errors, as demonstrated in this study, where 8% of patients reported injecting the weekly medication daily

Ultimately, Pfizer discontinued the entire program in April 2025, citing that the risk-benefit profile, including a potential case of drug-induced liver injury (DILI) in a recent study, did not support further development

If youre interested in trying GLP-1 medications, talk to your doctor about which one may be best for you

For example, semaglutide has suffered from limited supply in the US since 2022 due to its unprecedented demand, with these issues only recently being resolved [1]